Israel-based Univo announced a development agreement with Sanara Ventures' company Veoli to develop the formulation for a new cannabis inhaler.
The Cannabis Capital Conference returns to Toronto April 17-18!
What Happened
Under the terms of the partnership, Univo and Veoli will develop a unique, formula-based inhaler aimed to ease access to medical cannabis for THE elderly and children, allowing for accurate consumption of medical cannabis that is unattainable through smoking. Univo will exclusively produce potentiators and cartridges for the inhaler.
Why It's Important
Veoli is a medical device company, and its main technology is based on a unique nebulizer device that is able to convert liquid into isolated micron-sized drops that can be absorbed into the patient's lungs, thus allowing them to consume medical cannabis by inhaling a precise dosage without heating, evaporation or burning.
Veoli is backed by Sanara Ventures, an investment platform that is backed by Teva Pharmaceutical Industries Ltd TEVA and Philips.
As the only country in the Middle East that legalized medical marijuana and has recently allowed exports, Israel is positioned to become a regional cannabis power.
What's Next
Univo focuses on R&D and has an advanced in-house lab and a team of cultivators, biochemists and agricultural engineers. The company is working on developing a sophisticated Good Agricultural Practice greenhouse and a Good Manufacturing Practice facility that will be cultivating a variety of cannabis strains.
Related Links:
Israel-Based OurCrowd, 7thirty Partner To Create $30M Cannabis Tech VC Fund
Biotech Stock Applied DNA Sciences Jumps 50% On Cannabis Deal
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.